Author: Hannah Goold, Kevin P. Siu

Latest Posts

• Supreme Court affirms prohibition against patenting methods of medical treatment
• New Health Canada Guidance on Biosimilars to Streamline Submissions
• U.S. Supreme Court considers inducement liability for skinny-label generics
• Announcing Canadian AI Case Tracker
• Did the Federal Court of Appeal rein in overbreadth invalidity?

Practice Areas

• AI
• Blog
• Patents
• Pharmaceuticals

Tags

ai biologics biosimilars class actions competition copyright evidence fair dealing legislation methods of medical treatment overbreadth patentable subject matter patents pharmaceuticals privacy procedure regulatory TPMs trademarks